Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CHRISTUS SPOHN HEALTH SYSTEM CORPORATION

NPI: 1003885641 · ALICE, TX 78332 · Ambulatory Surgical Clinic/Center · NPI assigned 03/16/2006

$10.46M
Total Medicaid Paid
118,055
Total Claims
103,075
Beneficiaries
88
Codes Billed
2019-03
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBLOW, OSBERT (CEO)
NPI Enumeration Date03/16/2006

Related Entities

Other providers sharing the same authorized official: BLOW, OSBERT

ProviderCityStateTotal Paid
CHRISTUS SPOHN HEALTH SYSTEM CORPORATION CORPUS CHRISTI TX $17.62M
CHRISTUS SPOHN HEALTH SYSTEM CORPORATION BEEVILLE TX $6.22M
CHRISTUS SPOHN HEALTH SYSTEM CORPORATION KINGSVILLE TX $5.93M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 836 $3K
2020 2,657 $124K
2021 29,043 $1.70M
2022 38,040 $3.94M
2023 37,806 $3.77M
2024 9,673 $926K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 6,776 6,359 $5.33M
99283 Emergency department visit for the evaluation and management, moderate severity 11,006 10,527 $2.91M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,510 1,409 $631K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,351 1,316 $254K
71045 Radiologic examination, chest; single view 3,416 3,122 $186K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,253 3,159 $131K
80053 Comprehensive metabolic panel 10,711 9,459 $113K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4,694 2,373 $109K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,227 1,099 $102K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 12,602 11,068 $99K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,412 3,054 $75K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3,026 2,919 $61K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 872 630 $60K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,229 2,091 $55K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 163 151 $32K
96375 Therapeutic injection; each additional sequential IV push 1,233 1,088 $31K
70450 Computed tomography, head or brain; without contrast material 841 796 $26K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 957 940 $24K
81001 5,505 5,138 $19K
74177 Computed tomography, abdomen and pelvis; with contrast material 91 89 $17K
83690 2,219 2,067 $16K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 167 156 $16K
71046 Radiologic examination, chest; 2 views 306 295 $15K
84484 2,815 1,843 $9K
87070 639 627 $9K
96361 Intravenous infusion, hydration; each additional hour 372 318 $9K
80050 General health panel 56 42 $8K
86780 380 361 $7K
86703 361 346 $7K
72125 Computed tomography, cervical spine; without contrast material 90 90 $7K
86328 378 365 $6K
86803 298 285 $6K
87340 360 344 $5K
80061 Lipid panel 295 292 $5K
87086 Culture, bacterial; quantitative colony count, urine 703 660 $5K
86850 71 68 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg 494 454 $4K
87420 186 181 $4K
81003 1,509 1,145 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 485 416 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 392 366 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 53 50 $3K
J7030 Infusion, normal saline solution , 1000 cc 2,012 1,688 $3K
81025 221 208 $3K
83880 624 568 $3K
86738 100 83 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 39 38 $2K
84703 170 163 $2K
84481 67 66 $2K
82728 80 79 $2K
82652 43 43 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,366 1,193 $1K
84466 69 68 $1K
84443 Thyroid stimulating hormone (TSH) 251 240 $1K
83036 Hemoglobin; glycosylated (A1C) 139 136 $1K
82077 41 40 $1K
J2270 Injection, morphine sulfate, up to 10 mg 390 302 $976.35
84439 70 69 $949.88
83540 94 93 $925.10
80048 Basic metabolic panel (calcium, ionized) 927 754 $902.95
83605 819 619 $900.86
83550 94 93 $704.17
36415 Collection of venous blood by venipuncture 15,409 12,878 $647.47
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 51 41 $611.09
J0696 Injection, ceftriaxone sodium, per 250 mg 420 384 $583.91
87040 475 249 $512.03
85730 872 812 $511.58
85610 1,281 1,177 $504.56
87081 45 44 $439.38
86901 141 130 $386.84
86900 142 130 $386.84
86317 16 15 $319.88
82607 13 13 $292.10
83735 229 199 $223.51
80320 12 12 $175.60
85027 203 177 $123.16
82950 12 12 $119.52
J7120 Ringers lactate infusion, up to 1000 cc 144 105 $63.58
82803 16 13 $61.38
82550 43 39 $44.76
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 371 362 $12.00
87186 14 12 $10.19
A9270 Non-covered item or service 1,357 1,125 $0.00
82962 1,257 653 $0.00
96376 12 12 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 372 356 $0.00
36600 15 12 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 13 12 $0.00